Sort
85,873 grants matching “alzheimers”
Resource for MRI of Neurodegenerative Disorders
$1,194,122Michael W Weiner · Northern California Institute/Res/Edu · P41 · FY2012 · EB
Discovery of Novel Drugs for Alzheimer's Disease
$1,193,933University Of North Texas Hlth Sci Ctr · P01 · FY2005 · AG
Diabetes Status and Brain Amyloid in Middle Aged Hispanics
$1,193,897Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2019 · AG
Bioinformatics and Data Management Core
$1,193,875Gregory W Carter · Indiana University Indianapolis · U54 · FY2017 · AG
Clinical Core
$1,193,642Lon S Schneider · University Of Southern California · P30 · FY2021 · AG
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,193,602Linda J Van Eldik · University Of Kentucky · R01 · FY2021 · AG
Development of perivascular space mapping toolset as a diagnostic aid for Alzheimer's disease
$1,193,370Jeiran Choupan · Neuroscope Inc. · R44 · FY2024 · AG
Midwest Roybal Center for Health Promotion and Translation
$1,193,179Tanvi Bhatt · University Of Illinois At Chicago · P30 · FY2024 · AG
Laboratory of Neuro Imaging Resource (LONIR)
$1,193,086Arthur W Toga · University Of Southern California · P41 · FY2021 · EB
Oregon Alzheimer's Disease Center
$1,192,958Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2008 · AG
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal Endophenotype
$1,192,861Roberta Diaz Brinton · University Of Arizona · R01 · FY2018 · AG
Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease
$1,192,768Paul Gregor · Gismo Therapeutics, Inc. · R44 · FY2024 · AG
Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias
$1,192,643Aladdin Shadyab · University Of California, San Diego · R01 · FY2025 · AG
UC Davis Alzheimer's Disease Center Core
$1,192,537University Of California Davis · P30 · FY2004 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
$1,192,535David Eisenberg · University Of California Los Angeles · R01 · FY2024 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures
$1,192,535David Eisenberg · University Of California Los Angeles · R01 · FY2023 · AG
Flortaucipir PET and histopathology in frontotemporal lobar degeneration and Alzheimerâs disease
$1,192,500Keith A Josephs · Mayo Clinic Rochester · RF1 · FY2021 · NS
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
$1,192,133Shaoqin - Gong · University Of Wisconsin-Madison · UH3 · FY2021 · NS
Administrative Core
$1,192,122Bradley T Hyman · Massachusetts General Hospital · P30 · FY2022 · AG
MRI, Genetics & Cognitive Precursors of AD & Dementia
$1,192,094Philip A Wolf · Boston University Medical Campus · R01 · FY2007 · AG
An assistive-technology based Caregiver Training Program (CTP) to enhance caregiver effectiveness, well-being, and quality of life, which will improve overall care for individuals living with AD/ADRD.
$1,192,054Matthew Golden · Maphabit, Inc. · R44 · FY2024 · AG
Inherited Disease, Caregiving, and Social Networks
$1,191,952Laura M Koehly · National Human Genome Research Institute · ZIA · FY2021 · HG
Biological And Biochemical Characterization Of Sigma Receptors
$1,191,813Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2011 · DA
Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
$1,191,714Danny Jiong Jiong Wang · University Of Southern California · UH2 · FY2017 · NS
PRAZOSIN FOR AGITATION IN ALZHEIMER'S DISEASE
$1,191,547Elaine R. Peskind · University Of California, San Diego · U19 · FY2015 · AG